Telaglenastat is an orally bioavailable glutaminase inhibitor under investigation as an antineoplastic agent. It selectively and irreversibly inhibits the mitochondrial enzyme glutaminase, impairing glutamine metabolism in rapidly proliferating cells.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Telaglenastat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Barbital sodium
pharmaceutical raw material
Trihexyphenidyl
pharmaceutical raw material
Piperazine citrate
pharmaceutical raw material
Sulfathiazole sodium
pharmaceutical raw material
The international HS code for Telaglenastat (CAS 1439399-58-2) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[6-[4-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide
PRAAPINBUWJLGA-UHFFFAOYSA-N
C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F
Sourcing Telaglenastat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.